iASPP contributes to cell cortex rigidity, mitotic cell rounding, and spindle positioning.


Journal

The Journal of cell biology
ISSN: 1540-8140
Titre abrégé: J Cell Biol
Pays: United States
ID NLM: 0375356

Informations de publication

Date de publication:
06 12 2021
Historique:
received: 01 12 2020
revised: 03 08 2021
accepted: 19 09 2021
entrez: 27 10 2021
pubmed: 28 10 2021
medline: 24 12 2021
Statut: ppublish

Résumé

iASPP is a protein mostly known as an inhibitor of p53 pro-apoptotic activity and a predicted regulatory subunit of the PP1 phosphatase, which is often overexpressed in tumors. We report that iASPP associates with the microtubule plus-end binding protein EB1, a central regulator of microtubule dynamics, via an SxIP motif. iASPP silencing or mutation of the SxIP motif led to defective microtubule capture at the cortex of mitotic cells, leading to abnormal positioning of the mitotic spindle. These effects were recapitulated by the knockdown of the membrane-to-cortex linker Myosin-Ic (Myo1c), which we identified as a novel partner of iASPP. Moreover, iASPP or Myo1c knockdown cells failed to round up upon mitosis because of defective cortical stiffness. We propose that by increasing cortical rigidity, iASPP helps cancer cells maintain a spherical geometry suitable for proper mitotic spindle positioning and chromosome partitioning.

Identifiants

pubmed: 34705028
pii: 212730
doi: 10.1083/jcb.202012002
pmc: PMC8562848
pii:
doi:

Substances chimiques

Intracellular Signaling Peptides and Proteins 0
MAPRE1 protein, human 0
Microtubule-Associated Proteins 0
PPP1R13L protein, human 0
Repressor Proteins 0
Phosphoprotein Phosphatases EC 3.1.3.16
Myosin Type I EC 3.6.1.-
MYO1C protein, human EC 3.6.1.3

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2021 Mangon et al.

Références

Cell. 2015 Oct 22;163(3):712-23
pubmed: 26496610
Mol Biol Cell. 2014 Mar;25(5):658-68
pubmed: 24403606
J Cell Sci. 2009 Aug 15;122(Pt 16):2996-3004
pubmed: 19638416
J Biol Chem. 2012 Aug 17;287(34):28227-42
pubmed: 22696216
Curr Biol. 2008 Jan 22;18(2):91-101
pubmed: 18207738
Nat Struct Mol Biol. 2015 Jan;22(1):81-8
pubmed: 25437912
Nat Rev Mol Cell Biol. 2016 Aug;17(8):511-21
pubmed: 27353479
Dev Cell. 2020 Mar 9;52(5):563-573.e3
pubmed: 32032547
Curr Biol. 2012 Sep 25;22(18):1681-7
pubmed: 22902755
Nat Rev Mol Cell Biol. 2008 Apr;9(4):309-22
pubmed: 18322465
Sci Rep. 2016 Aug 02;6:30864
pubmed: 27480647
Biochim Biophys Acta. 2013 Feb;1834(2):499-507
pubmed: 23128140
Cell. 2009 Nov 25;139(5):891-906
pubmed: 19931152
Cytoskeleton (Hoboken). 2013 Nov;70(11):741-54
pubmed: 24136886
Dev Cell. 2013 May 13;25(3):270-83
pubmed: 23623611
J Cell Biol. 2013 Aug 19;202(4):637-51
pubmed: 23940118
Proc Natl Acad Sci U S A. 2016 Jun 21;113(25):E3501-8
pubmed: 27274053
PLoS One. 2013 Sep 06;8(9):e74448
pubmed: 24040250
Biology (Basel). 2017 Feb 17;6(1):
pubmed: 28218637
Nat Cell Biol. 2011 Mar;13(3):203-14
pubmed: 21336301
EMBO Rep. 2016 Aug;17(8):1106-30
pubmed: 27432284
Development. 2013 May;140(9):1843-56
pubmed: 23571210
Dev Cell. 2020 Jan 27;52(2):210-222.e7
pubmed: 31928973
Proc Natl Acad Sci U S A. 2017 Dec 12;114(50):E10687-E10696
pubmed: 29162697
Nat Cell Biol. 2014 Jun;16(6):561-73
pubmed: 24859005
Cancer Cell. 2017 Nov 13;32(5):561-573.e6
pubmed: 29033244
Adv Sci (Weinh). 2020 Aug 09;7(19):2001276
pubmed: 33042748
Nat Commun. 2017 Nov 2;8(1):1266
pubmed: 29097687
Nat Cell Biol. 2001 Dec;3(12):1069-75
pubmed: 11781568
Methods Mol Biol. 2017;1557:139-151
pubmed: 28078590
Trends Cell Biol. 2015 May;25(5):286-95
pubmed: 25548067
Nat Cell Biol. 2017 Jun;19(6):689-697
pubmed: 28530659
Structure. 2019 Oct 1;27(10):1485-1496.e4
pubmed: 31402222
Matrix Biol. 2018 Aug;68-69:180-193
pubmed: 29605717
J Cell Biol. 2016 May 9;213(3):315-28
pubmed: 27138257
J Cell Sci. 2016 Jul 15;129(14):2689-95
pubmed: 27401928
Curr Biol. 2017 Nov 6;27(21):3350-3358.e3
pubmed: 29107549
J Cell Sci. 2018 Jun 27;131(12):
pubmed: 29748378
Curr Biol. 2012 Oct 9;22(19):1800-7
pubmed: 22885064
Blood. 2012 Jan 12;119(2):445-53
pubmed: 22106344
Nat Genet. 2003 Feb;33(2):162-7
pubmed: 12524540
J Phys D Appl Phys. 2017 Feb 15;50(6):064002
pubmed: 28458398
Leuk Res. 2005 Feb;29(2):179-83
pubmed: 15607367
J Cell Biol. 2014 Jun 23;205(6):791-9
pubmed: 24958772
Nat Commun. 2019 Mar 19;10(1):1249
pubmed: 30890704
J Cell Biol. 1997 Nov 3;139(3):683-93
pubmed: 9348285
Semin Cancer Biol. 2015 Dec;35:62-70
pubmed: 26343578
Dev Cell. 2014 Apr 28;29(2):159-69
pubmed: 24780736
Cancer Cell. 2013 May 13;23(5):618-33
pubmed: 23623661
Clin Cancer Res. 2011 Nov 1;17(21):6924-33
pubmed: 21926165
Ultramicroscopy. 2016 Jan;160:168-181
pubmed: 26521163
J Cell Biol. 2008 Feb 25;180(4):739-46
pubmed: 18283112
J Cell Biol. 2012 Mar 19;196(6):801-10
pubmed: 22412018
Micron. 2012 Dec;43(12):1246-51
pubmed: 22494854
Front Cell Dev Biol. 2020 Aug 06;8:687
pubmed: 32850812
Biochem J. 2013 Feb 1;449(3):649-59
pubmed: 23088536
Bioessays. 2012 Dec;34(12):1017-20
pubmed: 22996605
Nat Commun. 2021 Apr 23;12(1):2409
pubmed: 33893302
Cell Death Dis. 2014 Oct 23;5:e1492
pubmed: 25341046
Nat Commun. 2019 Feb 15;10(1):771
pubmed: 30770806
Proc Natl Acad Sci U S A. 2009 Jul 21;106(29):11972-7
pubmed: 19574460
J Cell Biol. 2010 May 31;189(5):901-17
pubmed: 20513769

Auteurs

Aurélie Mangon (A)

Centre de Recherche en Cancérologie de Marseille, Institut National de la Santé et de la Recherche Médicale, Institut Paoli-Calmettes, Aix-Marseille Université, Centre National de la Recherche Scientifique, Marseille, France.

Danièle Salaün (D)

Centre de Recherche en Cancérologie de Marseille, Institut National de la Santé et de la Recherche Médicale, Institut Paoli-Calmettes, Aix-Marseille Université, Centre National de la Recherche Scientifique, Marseille, France.

Mohamed Lala Bouali (ML)

Centre de Recherche en Cancérologie de Marseille, Institut National de la Santé et de la Recherche Médicale, Institut Paoli-Calmettes, Aix-Marseille Université, Centre National de la Recherche Scientifique, Marseille, France.

Mira Kuzmić (M)

Centre de Recherche en Cancérologie de Marseille, Institut National de la Santé et de la Recherche Médicale, Institut Paoli-Calmettes, Aix-Marseille Université, Centre National de la Recherche Scientifique, Marseille, France.

Sabine Quitard (S)

Centre de Recherche en Cancérologie de Marseille, Institut National de la Santé et de la Recherche Médicale, Institut Paoli-Calmettes, Aix-Marseille Université, Centre National de la Recherche Scientifique, Marseille, France.

Sylvie Thuault (S)

Centre de Recherche en Cancérologie de Marseille, Institut National de la Santé et de la Recherche Médicale, Institut Paoli-Calmettes, Aix-Marseille Université, Centre National de la Recherche Scientifique, Marseille, France.

Daniel Isnardon (D)

Centre de Recherche en Cancérologie de Marseille, Institut National de la Santé et de la Recherche Médicale, Institut Paoli-Calmettes, Aix-Marseille Université, Centre National de la Recherche Scientifique, Marseille, France.

Stéphane Audebert (S)

Centre de Recherche en Cancérologie de Marseille, Institut National de la Santé et de la Recherche Médicale, Institut Paoli-Calmettes, Aix-Marseille Université, Centre National de la Recherche Scientifique, Marseille, France.

Pierre-Henri Puech (PH)

Laboratoire Adhésion et Inflammation, Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique, Aix Marseille Université, Turing Center for Living Systems, Marseille, France.

Pascal Verdier-Pinard (P)

Centre de Recherche en Cancérologie de Marseille, Institut National de la Santé et de la Recherche Médicale, Institut Paoli-Calmettes, Aix-Marseille Université, Centre National de la Recherche Scientifique, Marseille, France.

Ali Badache (A)

Centre de Recherche en Cancérologie de Marseille, Institut National de la Santé et de la Recherche Médicale, Institut Paoli-Calmettes, Aix-Marseille Université, Centre National de la Recherche Scientifique, Marseille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH